Healthcare
Ansell Ltd.(ANSLF)
Live Price
Offline$19.59
+0.00% today
1Y Change
+8.78%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $2.62B
- Revenue Growth
- +23.7%
- EPS Growth
- +17.7%
- Dividend Yield
- 3.1%
Coverage: 249 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ansell Ltd. (ANSLF) is a Healthcare stock with a market cap of $2.62B and listed on OTC. The stock last traded around $19.59 and up 8.8% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +23.7%, EPS growth of +17.7%, a dividend yield of 3.1%. What stands out right now is revenue +23.7%, EPS +17.7%, free cash flow -18.9% with operating margin 5.4% and ROIC 5.8%. The dividend matters to the case here, with a current yield around 3.1%. Valuation is more restrained than many high-expectation growth names at P/E 19.2 and price/sales 1.3. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines ANSLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+23.7% vs +7.6% peer median
Operating Margin
Below sector median
+5.4% vs +19.4% peer median
P/E
Below sector median
19.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
Q2 2026 was reported on Apr 13, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +23.7% and EPS at +17.7%, with operating margin around 5.4%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 24, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 2 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
Q2 2026 Apr 13, 2026 | +0.0% | +0.0% | +0.0% | +0.0% |
Q4 2025 Dec 3, 2025 | +66.7% | +0.0% | +0.0% | -15.8% |
Benchmark Edge
ANSLF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ANSLF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ANSLF Max Drawdown
-21.68%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ANSLF and SPY.
Company Overview
Ansell Limited
Other OTC
Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia. P. D. Holdings Pty. Ltd. operates as a current subsidiary of Ansell Limited.
- Leadership
- Nathalie Ahlstrom
- IPO Date
- Oct 15, 2010
- Employees
- 15.0k
- Street Address
- 678 Victoria Street
- Mailing
- Richmond, VIC, 3121
- Region
- Richmond, VIC, AU
- Reporting Currency
- USD
- Investor Line
- 61 3 9270 7229
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 19.2
- EV/EBITDA
- 10.4
- Price/Sales
- 1.3
- Price/Book
- 1.3
Growth
- Revenue
- +23.7%
- EPS
- +17.7%
- Free Cash Flow
- -18.9%
Profitability
- Gross Margin
- 41.2%
- Operating Margin
- 5.4%
- Net Margin
- 5.2%
- ROE
- 7.0%
- ROIC
- 5.8%
Balance Sheet
- Debt/Equity
- 0.46
- Current Ratio
- 0.83
Ownership & Float
- Float
- 142.04M
- Insider Owned
- 1.6%
- Institutional Owned
- 65.3%
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.